Omega Therapeutics Inc (OMGA)
2.27
-0.08
(-3.40%)
USD |
NASDAQ |
Apr 26, 16:00
2.28
+0.01
(+0.44%)
After-Hours: 20:00
Omega Therapeutics Shareholders Equity (Quarterly): 58.02M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.02M |
| September 30, 2023 | 76.04M |
| June 30, 2023 | 95.92M |
| March 31, 2023 | 123.00M |
| December 31, 2022 | 105.97M |
| September 30, 2022 | 133.65M |
| June 30, 2022 | 157.38M |
| Date | Value |
|---|---|
| March 31, 2022 | 181.35M |
| December 31, 2021 | 200.63M |
| September 30, 2021 | 220.34M |
| June 30, 2021 | -92.48M |
| March 31, 2021 | -77.88M |
| December 31, 2020 | -64.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-92.48M
Minimum
Jun 2021
220.34M
Maximum
Sep 2021
85.95M
Average
105.97M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Fate Therapeutics Inc | 368.42M |
| Ocular Therapeutix Inc | 91.13M |
| AnaptysBio Inc | 88.10M |
| Amneal Pharmaceuticals Inc | 19.78M |
| Stoke Therapeutics Inc | 159.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 204.37M |
| Total Liabilities (Quarterly) | 146.35M |
| Debt to Equity Ratio | 0.3255 |
| Current Ratio | 3.353 |
| Net Debt Paydown Yield | 0.12% |